S&P Futures
3,980.00 +9.50 (+0.24%) Dow Futures
32,247.00 -11.00 (-0.03%) Nasdaq Futures
12,805.00 +98.00 (+0.77%) Russell 2000 Futures
1,742.10 +1.10 (+0.06%) Crude Oil
70.05 -0.85 (-1.20%) Gold
1,982.90 +33.30 (+1.71%)
After hours:
Chart Events
Performance Outlook
| Previous Close | 43.90 |
| Open | 43.63 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 800 |
| Day's Range | 41.83 - 43.87 |
| 52 Week Range | 35.33 - 64.02 |
| Volume | |
| Avg. Volume | 2,082,642 |
| Market Cap | 16.74B |
| Beta (5Y Monthly) | 1.22 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.10 |
| Earnings Date | May 03, 2023 - May 08, 2023 |
| Forward Dividend & Yield | 1.80 (4.07%) |
| Ex-Dividend Date | Mar 31, 2023 |
| 1y Target Est | 53.41 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for VTR
Related Research
- Ventas, Inc.Analyst Report: Ventas, Inc.Ventas owns a diversified healthcare portfolio of over 1,200 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes over 40 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 3% of net operating income.RatingFair ValueEconomic Moat9 days agoMorningstar
- Business Wire
Ventas Declares First Quarter 2023 Dividend of $0.45 per Common Share
CHICAGO, March 14, 2023--Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") today announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share. The dividend will be payable in cash on April 13, 2023 to stockholders of record as of the close of business on April 3, 2023.
- Insider Monkey
Will Ventas (VTR) Generate Strong Returns for its Shareholders?
Baron Funds, an investment management company, released its “Baron Real Estate Income Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the fund rose 2.10% (Institutional Shares) compared to a 4.90% return for the MSCI US REIT Index (the “REIT Index”). For 2022, the fund declined […]
- Zacks
Is it Wise to Hold on to Healthpeak (PEAK) Stock for Now?
Healthpeak's (PEAK) focus on enhancing its life-science real-estate assets, capital-recycling moves and a solid balance sheet bodes well. Stiff competition from peers and rising interest rates are woes.
